(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 8.73% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.97%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.95%.
Rxsight's revenue in 2026 is $127,478,000.On average, 12 Wall Street analysts forecast RXST's revenue for 2026 to be $5,819,121,327, with the lowest RXST revenue forecast at $5,176,645,955, and the highest RXST revenue forecast at $6,653,262,998. On average, 12 Wall Street analysts forecast RXST's revenue for 2027 to be $6,126,698,132, with the lowest RXST revenue forecast at $5,437,444,592, and the highest RXST revenue forecast at $7,165,753,018.
In 2028, RXST is forecast to generate $6,796,909,232 in revenue, with the lowest revenue forecast at $5,798,423,023 and the highest revenue forecast at $8,871,707,275.